A detailed history of Tower Research Capital LLC (Trc) transactions in Insmed Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,293 shares of INSM stock, worth $169,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,293
Previous 23,509 90.25%
Holding current value
$169,338
Previous $1.58 Million 89.4%
% of portfolio
0.0%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $1.32 Million - $1.68 Million
-21,216 Reduced 90.25%
2,293 $167,000
Q2 2024

Aug 13, 2024

BUY
$22.0 - $69.71 $398,266 - $1.26 Million
18,103 Added 334.87%
23,509 $1.58 Million
Q1 2024

May 15, 2024

SELL
$25.72 - $29.94 $205,297 - $238,981
-7,982 Reduced 59.62%
5,406 $146,000
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $265,629 - $359,995
11,342 Added 554.35%
13,388 $414,000
Q3 2023

Nov 14, 2023

SELL
$19.86 - $26.93 $65,021 - $88,168
-3,274 Reduced 61.54%
2,046 $51,000
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $5,507 - $7,068
335 Added 6.72%
5,320 $112,000
Q1 2023

May 09, 2023

BUY
$16.26 - $21.73 $55,072 - $73,599
3,387 Added 211.95%
4,985 $85,000
Q4 2022

Feb 10, 2023

SELL
$16.98 - $23.15 $545,907 - $744,272
-32,150 Reduced 95.26%
1,598 $32,000
Q3 2022

Nov 10, 2022

BUY
$20.88 - $28.21 $259,162 - $350,142
12,412 Added 58.17%
33,748 $727,000
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $84,889 - $127,855
4,973 Added 30.39%
21,336 $421,000
Q1 2022

May 12, 2022

BUY
$20.42 - $28.13 $81,332 - $112,041
3,983 Added 32.17%
16,363 $385,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $120,647 - $155,877
-4,660 Reduced 27.35%
12,380 $338,000
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $188,708 - $247,606
8,402 Added 97.27%
17,040 $469,000
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $76,353 - $113,755
3,159 Added 57.66%
8,638 $246,000
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $31,957 - $43,857
990 Added 22.05%
5,479 $187,000
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $41,859 - $53,958
1,331 Added 42.15%
4,489 $150,000
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $167,388 - $222,111
-6,438 Reduced 67.09%
3,158 $101,000
Q2 2020

Aug 13, 2020

BUY
$14.11 - $29.42 $135,399 - $282,314
9,596 New
9,596 $264,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $1,499 - $3,737
-110 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$16.12 - $24.98 $10,042 - $15,562
-623 Reduced 84.99%
110 $3,000
Q3 2019

Nov 05, 2019

BUY
$15.49 - $25.78 $11,354 - $18,896
733 New
733 $13,000
Q2 2019

Aug 13, 2019

SELL
$23.0 - $32.19 $3,266 - $4,570
-142 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$13.91 - $31.15 $1,975 - $4,423
142 New
142 $4,000
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $22,353 - $36,034
-1,927 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$18.95 - $28.08 $36,516 - $54,110
1,927 New
1,927 $39,000
Q2 2018

Aug 15, 2018

SELL
$20.0 - $29.72 $80,680 - $119,890
-4,034 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $83,332 - $126,747
3,842 Added 2001.04%
4,034 $91,000
Q4 2017

Feb 09, 2018

SELL
$26.43 - $31.78 $51,908 - $62,415
-1,964 Reduced 91.09%
192 $6,000
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $25,031 - $67,288
2,156
2,156 $67,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.